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Abstract
Introduction. Arterial hypertension (AH) and cigarette smoking are a leading health and social problem in Polish 
population. Still around 24% of Poles are chronic smokers. Despite the high risk of cardio-vascular and oncological 
complications the number of papers assessing wellbeing and health condition of chronic smokers is low.
Material and methods. As part of the Moltest Kardio+ program 425 citizens of pomorskie voivodeship (223 males, 
52.47%) were examined. Inclusion criteria were age between 50 and 79 years and history of smoking with more than  
30 pack years. Program consisted of one visit during which medical history, anthropometric measurements and 
three separate blood pressure measurements were taken. The results were then compared to the general population 
(NATPOL 2011 study).
Results. There were no differences between SBP and DBP values in Moltest Kardio+ and NATPOL 2011 popula-
tions. Prevalence of AH was not significantly different in both populations. Significant differences in SBP according 
to number of pack years were noted. In Moltest study women had significantly lower BMI than those in general 
population, whereas men’s BMI was significantly higher.
Conclusions. Mean SBP and DBP values and prevalence of AH are not significantly different in these two groups. 
Number of pack years had a significant effect on SBP values in smokers. Entirely opposite relations between smoking 
and BMI index values were observed in female and male smokers. Higher prevalence of body mass disorders and 
concomitance of AH and chronic smoking in male smokers resulting in increased cardiovascular risk requires to 
undertake more intense preventive measures.
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Streszczenie
Wstęp. Nadciśnienie tętnicze oraz palenie papierosów stanowią istotny problem zdrowotny i społeczny w populacji 
polskiej. Wciąż około 24% Polaków nałogowo pali papierosy. Mimo wysokiego ryzyka powikłań naczyniowo-ser-
cowych i onkologicznych, istnieje niewielka liczba publikacji oceniających stan zdrowia wieloletnich palaczy.
Materiał i metody. W ramach programu Moltest Kardio+ zbadano 425 mieszkańców (223 mężczyzn, 52,47%) wojew-
ództwa pomorskiego. Do badania kwalifikowano osoby w wieku od 50 do 79 lat, z wywiadem tytoniowym powyżej 30 
paczkolat. Badanie składało się z jednej wizyty, podczas której zebrano wywiad, wykonano pomiary antropometryczne 
oraz 3-krotny pomiar ciśnienia tętniczego. Otrzymane wyniki porównano z populacją ogólną (badanie NATPOL 2011).
Wyniki. Nie zaobserwowano różnic pomiędzy wartościami SBP i DBP w populacji Moltest Kardio+ i NATPOL 
2011. Rozpowszechnienie nadciśnienia tętniczego nie różniło się istotnie w obu populacjach. Zauważono istotne 
statystycznie różnice w SBP w zależności od wypalonych paczkolat. Kobiety z grupy Moltest miały istotnie niższe 
BMI od kobiet z populacji ogólnej, natomiast u mężczyzn wartości BMI były istotnie wyższe.
Wnioski. Średnie wartości SBP i  DBP oraz rozpowszechnienie nadciśnienia tętniczego nie różni się istotnie 
w  badanych grupach. Liczba paczkolat w  wywiadzie miała znaczący wpływ na wartości SBP wśród palaczy. 
Zaobserwowano całkowicie odmienne związki palenia papierosów i wartości wskaźnika BMI u kobiet i mężczyzn. 
Większe rozpowszechnienie zaburzeń masy ciała i współwystępowanie nadciśnienia tętniczego i nałogowego palenia tytoniu 
w populacji mężczyzn wymaga wzmożonych działań prewencyjnych ze względu na wysokie ryzyko sercowo-naczyniowe.
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Introduction
Hypertension is the most common cardiovascular 
condition, present in about 32% of adult Poles [1, 2]. 
When untreated, it may lead to severe complications 
such as coronary artery disease, myocardial infarc-
tion, peripheral arterial disease, and stroke. Both 
hypertension and smoking are modifiable risk factors 
for cardiovascular disease [3], which remain major 
causes of mortality among adults despite advances 
in prevention and treatment. Substances present in 
tobacco smoke irritate the endothelium and have 
a proinflammatory and prothrombotic effect, which 
accelerates development of atherosclerotic lesions 
[4], and increase the risk of lung cancer and other 
malignancies. In addition, nicotine present in tobac-
co activates the sympathetic system, leading to an 
acute increase in blood pressure and heart rate [5]. 
However, few studies were reported on the long-term 
effect of smoking on blood pressure values. 
Widespread initiatives aiming to reduce the prev-
alence of smoking have not yet achieved the desired 
effects in Poland, with about 24% of adult Poles 
continuing to smoke [6]. It has been shown that 
reduction in tobacco use is the most cost-effective 
strategy to prevent cardiovascular disease [7]. Smok-
ing itself results in a twofold increase in the risk of 
cardiovascular disease, and this risk is increased four 
times in the presence of one additional independent 
risk factor (e.g., hypertension).
The aim of our study was to evaluate the preva-
lence of hypertension among chronic smokers from 
the Pomeranian voivodeship who participated in the 
Moltest Kardio+ programme and to compare these 
data with the findings in the general population at 
the same age range (based on the NATPOL 2011 
study results) [8].
Material and methods
The present analysis is based on the results of the 
Moltest Kardio+ research project undertaken in 
2016–2017 at the Department of Preventive Medi-
cine and Education, Chair of Hypertension and Di-
abetology, Faculty of Medicine, Medical University 
of Gdansk. Within this project, 425 residents of 
the Pomeranian voivodeship (223 men, 52.47%) 
who participated in the lung cancer screening pro-
gramme (Moltest BIS) undertaken by the Depart-
ment of Thoracic Surgery at the Medical Universi-
ty of Gdansk were examined. The study included 
subjects aged 50–79 years with a  smoking history 
of more than 30 pack-years, including both active 
and past smokers. Each participant gave a  written 
informed consent for participation in the study. The 
Moltest Kardio+ research project was approved by 
the Ethics Committee at the Medical University 
of Gdańsk (approval No. NKBBN/173/2016). All 
procedures were performed in accordance with the 
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Declaration of Helsinki on the treatment of human 
subjects. The cardiology module of the study was 
based on a single visit that included history taking 
based on standardized questionnaire, anthropomet-
ric measurements, and 3 blood pressure measure-
ments. The questionnaire included detailed ques-
tions on the history of smoking and cardiovascular 
risk factors including hypertension. Body weight, 
height, and neck, waist, and hip circumference were 
measured. Blood pressure measurements were per-
formed during the single visit in accordance with 
the Polish Society of Hypertension guidelines [9], 
in the sitting position, on the right arm, and after 
the subject rested for several minutes. The interval 
between subsequent measurements was at least one 
minute. The subjects had to refrain from smoking 
and drinking coffee for at least 30 minutes before 
the assessment. Blood pressure measurements were 
performed using an automated device (UA-787+ 
Blood Pressure Monitor, A&D Medical), with the 
mean of the second and third measurement taken as 
the blood pressure value. For comparison of blood 
pressure values between the Moltest and NATPOL 
study population, measurements from only one vis-
it in the NATPOL 2011 study were taken. All the 
data from NATPOL 2011 study necessary for the 
purposes of our research, was provided by the au-
thors of afore-mentioned study. The design of the 
NATPOL 2011 was reported elsewhere [10].
For the purpose of statistical analysis, the study 
population was divided into three groups based 
on the number of pack years: Group A ≤ 35 pack 
years, Group B 36–45 pack years, and Group C ≥ 
45 pack years.
Statistical analysis
Statistical analysis was performed using the R statis-
tical package (version 3.2.3).
Qualitative variables were expressed as percenta - 
ges. Quantitative variables were expressed as the arith-
metic mean and 95% confidence interval (95% CI).
Normal data distribution was verified using the 
Shapiro-Wilk test and by visual interpretation of the 
Q-Q plot. Variance homogeneity assumption was 
verified using the F test and the Brown-Forsyth test, 
respectively, for two groups and multiple (n > 2) 
groups.
Significance of the effect of a continuous variable 
in two independent groups was verified using the Stu-
dent t test or nonparametric Mann-Whitney U test. 
Univariate ANOVA was used for three groups. The 
Tukey’s HSD Tukey was used for post-hoc analysis. 
Analysis of covariance was used to evaluate the effect 
of the number of pack years and gender on blood 
pressure. Age was used as covariate.
Differences between qualitative variables were 
evaluated using the chi-square test or the exact Fisher 
test. Research hypotheses were verified using two-sid-
ed tests. Statistical significance was set at P < 0.05.
Results
The mean age did not differ between the two popula-
tion both in men (61.67 ± 6.51 years in the Moltest 
study group vs. 61.29 ± 7.96 years in the NATPOL 
study group) and in women (61.47 ± 5.91 years in 
the Moltest study group vs. 62.81 ± 8.14 years in the 
NATPOL study group).
The mean systolic blood pressure (SBP) was high-
er in men compared to women (137.0 ± 17.3 mmHg 
vs. 133.7 ± 18.4 mmHg, P = 0.03), while no dif-
ference was seen for diastolic blood pressure (DBP) 
(81.9 ± 6.5 mmHg vs. 80.8 ± 8.9 mmHg, P = 0.27) 
(Table I).
No differences were found between SBP and DBP 
in the Moltest Kardio+ and NATPOL 2011 study 
populations. The prevalence of hypertension, defined 
as SBP ≥ 140 mmHg or DBP ≥ 90 mmHg or use 
of antihypertensive drugs, did not differ between 
the two populations in both men (Moltest Kardio+: 
67.82% vs. NATPOL 2011: 62.47%, P = 0.3) and 
women (Moltest Kardio+: 56.43% vs. NATPOL 
2011: 63.72%, P = 0.08). The characteristics of the 
compared populations are shown in Tables II and III.
Differences in SBP were found in relation to the 
number of pack years. After eliminating the effect 
of age, post-hoc tests showed that SBP increased 
Table I. Comparison of mean SBP and DBP in men and women in the Moltest cohort
MOLTEST
Women Men P value
SBP [mmHg]
Mean (95% CI) 133.7 (131.1–136.3) 137.0 (134.6–139.2) 0.03
DBP [mmHg]
Mean (95% CI) 80.8 (79.6–82.1) 81.9 (80.6–83.2) 0.27
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Table II. Baseline characteristic of the study population — WOMEN
Women
MOLTEST
(n = 202)
NATPOL
(n = 576)
P value
Age
Mean (95% CI) 61.4 (60.6–62.2) 62.81 (62.1–63.5) 0.17
SBP [mmHg]
Mean (95% CI) 133.7 (131.1–136.3) 136 (134.3–137.7) 0.26
DBP [mmHg]
Mean (95% CI) 80.84 (79.6–82.1) 82.3 (81.5–83.1) 0.08
BMI
Mean (95% CI) 27.13 (26.46–27.80) 28.73 (28.28–29.18) < 0.01
Waist circumference [cm] 
Mean (95% CI) 91.6 (89.9–93.2) 93.6 (92.5–94.7) 0.08
BMI
20–30 (%; 95% CI)
> 30 (%; 95%CI)
70.79; 64.00–76.96
26.73; 20.76–33.40
62.63; 58.51–66.62
34.21; 30.32–38.27
0.04
0.06
AH* (%; 95% CI) 56.43; 49.30–63.38 63.72; 59.64–67.65 0.08
Pack-years
Mean (95% CI) 38.1 (36.6–39.6) 10.0 (8.8–11.3)
< 0.01
*SBP ≥ 140 or DBP ≥ 90 or diagnosed AH; CI — confidence interval
Tabela III. Baseline characteristic of the study population — MEN
MEN
MOLTEST
(n = 223)
NATPOL
(n = 469)
P value
Age
Mean (95% CI) 61.7 (60.8–62.5) 61.3 (60.6–62.0) 0.16
SBP [mmHg]
Mean (95% CI) 137.0 (134.7–139.2) 139.3 (137.5–141.1) 0.24
DBP [mmHg]
Mean (95% CI) 81.9 (80.6–83.2) 82.8 (81.9–83.7) 0.33
BMI
Mean (95% CI) 29.45 (28.83–30.07) 28.35 (27.96–28.75)
< 0.01
Waist circumference [cm]
Mean (95% CI) 105.60 (103.97–107.29) 102.32 (101.31–103.33) < 0.01
BMI
20–30 (%; 95% CI)
> 30 (%; 95%CI)
59.46; 52.68–65.98
39.64; 33.16–46.40
63.85; 59.29–68.24
32.47; 28.21–36.95
0.29
0.08
AH* (%; 95% CI) 66.82; 60.22–72.96 62.47; 57.92–66.87 0.30
Pack-years
Mean (95% CI) 47.0 (44.6–49.3) 21.0 (19.1–22.9)
< 0.01
*SBP ≥ 140 or DBP ≥ 90 or diagnosed AH; CI — confidence interval
with the number of pack years. A  difference was 
shown between Groups A  (< 35 pack years) and 
C (> 45 pack years) (P < 0.05). The difference be-
tween Groups A and B was of borderline significance 
(P < 0.051). Such an effect was not shown for DBP 
(Table IV).
After eliminating the effect of age due to signifi-
cant differences, analysis of covariance did not show 
differences in blood pressure (both SBP and DBP) 
between active and former smokers (Table V).
When comparing the two populations, differences 
regarding body weight were noted between chronic 
arterial hypertension 2018, vol. 22, no. 2
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Table IV. Comparison of SBP and DBP values in active and past smokers (age adjusted) in the Moltest cohort
Active smokers Past smokers P value
W M W M
SBP [mmHg]
Mean (95% CI) 133.4 (130.7–136.9) 135.6 (133.4–139.4) 134.3 (129.8–137.8) 138.7 (133.7–141.6) 0.19
DBP [mmHg]
Mean (95% CI) 80.6 (78.7–81.9) 81.6 (79.7–82.7) 81.2 (79.6–83.7) 82.2 (80.9–85.0) 0.65
*P values of Active smokers in general (both women and men) vs Past smokers in general (both women and men) analysis in terms of SBP and DBP respectively
Table V. Correlations between number of pack-years and SBP and DBP values in study cohort (Moltest)
Pack-years P value Post hoc P value
≤ 35 (A)
(n = 174)
36–45 (B)
(n = 130)
45 (C)
(n = 121)
A vs B A vs C B vs C
SBP [mmHg]
Mean (95% CI) 132.5 (130.0–135.0) 137.4 (134.2–140.5) 137.6 (134.1–141.1) 0.02 0.051 0.045 0.99
DBP [mmHg]
Mean (95% CI) 81.4 (80.1–82.7) 81.2 (79.7–82.7) 81.6 (79.6–83.5) 0.95 — — —
Age
Mean (95% CI) 59.8 (58.9–60.7) 62.3 (61.4–63.4) 63.1 (61.9–64.3) < 0.01 < 0.01 < 0.01 0.62
smokers and the general population. Women in the 
Moltest study population had lower body mass in-
dex (BMI) compared to those in the general popu-
lation (27.1 ± 4.8 vs. 28.7 ± 5.5, P < 0.01), while 
the reverse was true in men (29.5 ± 4.7 vs. 28.4 ± 
4.4, P < 0.01).
Discussion
Some studies showed that, paradoxically, active 
smokers had lower blood pressure values compared 
to past smokers or never smokers [10, 11]. In our 
study, SBP and DBP values were not significantly 
different than these in general population based on 
NATPOL 2011 (Table II and III). Multiple studies 
attempted to explain this phenomenon [12]. De-
spite this, the role of smoking as a  risk factor for 
hypertension remains unclear. Ambulatory blood 
pressure monitoring (ABPM) showed that over 24 
hours, smokers had higher blood pressure values 
compared to non-smokers but this was not evident 
in office measurements [13, 14]. These differences 
may be explained by a short-term effect on the sym-
pathetic system after a cigarette is smoked [15]. This 
may have no effect on office blood pressure measure-
ments but in heavy smokers, it may affect the mean 
daytime blood pressure in ABPM. Short-term blood 
pressure-raising effect of a  smoked cigarette might 
have had no effect on our findings as in the Moltest 
study, the time from the initial patient presentation 
to the first blood pressure measurement was more 
than 30 minutes and the patients did not smoke 
during that time.
In our study group, a  higher prevalence of hy-
pertension was noted in male smokers compared 
to the general population (66.82% vs. 62.47%, P = 
0.30), while hypertension in female smokers was less 
prevalent (56.43% vs. 63.72%, P = 0.08) but these 
differences were not significant. Considering often 
contradictory results of previously published studies 
and trends noted in our analysis, it is worth pursuing 
research on the associations between smoking and 
hypertension, as well as comorbidities and cumula-
tive risk factors in this group.
An important rationale for our analysis is the syn-
ergistic effect of smoking and hypertension on the risk 
of cardiovascular events. It has been shown that conco-
mitant presence of smoking and hypertension increases 
the risk of myocardial infarction and ischemic and hae-
morrhagic stroke more than it could be expected based 
on the sum of separate effects of these risk factors [17].
According to the CDC data for 2005–2009, the 
annual mortality due to smoking-related disease in 
the United States was 437,000, including 34.52% 
of deaths due to cardiovascular disease, 29.19% of 
deaths due to lung cancer, and 22.99% of deaths 
due to chronic obstructive lung disease [18]. The 
remaining causes of death included smoking-related 
malignancies other than lung cancer, other lung di-
sease such as emphysema or pneumonia, and com-
plications of diabetes.
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In comparison to other European countries, the 
prevalence of smoking in Poland, i.e. about 20% 
depending on the study, which is close to the overall 
European median. During the last 30 years, the rates 
of smoking in the Polish population decreased sig-
nificantly (65% of men and 32% of women in 1980 
vs. 32.6% of men and 21.9% of women in 2015) 
[19]. However, this trend has been halted among 
women. In 2000–2010, the rate of smoking among 
men was reduced by 12%, compared to only 3% 
among women, based on the NATPOL 2011 study 
findings. As a result, Poland is among countries with 
the highest rate of smoking among women [20]. 
Thus, identification of female smokers, monitoring 
their health status including blood pressure values, 
and offering support and motivation for smoking 
cessation seem particularly important.
Multiple studies showed that body weight in regular 
smokers is lower compared to non-smokers [21, 22]. 
This is probably related to the actions of nicotine 
that increase energy expenditure and reduce appetite 
[23]. In our study, we found the same relation in 
women, while smoking men had significantly higher 
body mass compared to the general population. As 
the number of pack years was higher in men (mean 
46.84 vs. 37.19 in women), this might have reflected 
a special subset of the population engaging in mul-
tiple unhealthy behaviours (e.g., smoking for many 
years, low physical activity, poor diet etc.). Available 
studies confirm higher BMI in heavy smokers com-
pared to light and moderate smokers [24, 25]. The 
observed relations deserve further studies and more 
widespread analyses.
Despite lacking evidence for a  direct effect of 
chronic smoking on the development of hyperten-
sion, continuing high prevalence of this habit, its 
negative effect on life expectance, and synergistic 
effects of risk factors in smokers all call for particular 
attention, educational efforts, and screening in this 
group in regard to not only malignancies but also 
cardiovascular disease.
Limitations
Analysis based on blood pressure measurements per-
formed during a single visit was a limitation of our 
study. It has been shown that blood pressure decreas-
es during subsequent visits, thus reducing the size of 
the subset with the diagnosis of hypertension [16]. 
Some subjects would require a second visit to con-
firm the diagnosis of hypertension. Of note, the 
Moltest study was performed in voluntarily recruited 
participants. For this reason, the study cohort might 
have been characterized by an increased interest in 
personal health, resulting in a  lower prevalence of 
hypertension and lower blood pressure values com-
pared to a randomly selected sample, such as the one 
used in the NATPOL 2011 study.
Conclusions
1. Mean systolic and diastolic blood pressure values 
did not differ between chronic smokers and the 
general population.
2. Comparison of the prevalence of hypertension, 
defined as increase blood pressure values or taking 
antihypertensive medications, did not show sig-
nificant differences between smokers and a repre-
sentative sample of the general Polish population.
3. No differences in the rate of hypertension were 
noted between active and past smokers. After 
eliminating the effect of age, our analysis showed 
higher systolic blood pressure values with an in-
creasing number of pack-years.
4. Different directions of the relation between smoking 
and BMI were observed in women and men but 
elucidating the determinants of these relations would 
require a comprehensive analysis of all risk factors.
5. Due to a  higher prevalence of abnormal body 
mass and concomitant presence of hypertension 
and chronic smoking in a  large proportion of 
men, this group is at a particularly high risk of 
cardiovascular disease and should be a target for 
intensified preventive efforts.
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